MaxCyte Webinars

  1. Non-Viral Tools For Genome Engineering 11/9/2024

    In this segment, Dr. Robert Hariri, Chairman, founder, and CEO of Celularity, and Paul Kopesky, Ph.D., VP of Cell Therapy Process Development at Beam Therapeutics each share their own take on the tools, platforms, and non-viral approaches they have used for genome engineering of cell therapeutics.

  2. The State Of CRISPR And Gene Editing Presentation 8/2/2024

    Listen in on this session from The State of CRISPR and Gene Editing Summit which focus on the use of CRISPR-based therapies in clinical settings using electroporation. 

  3. Scalable Cell Transfection Technology From Concept To Manufacturing 8/2/2024

    Improve your gene editing and cell manufacturing with electroporation platforms and gene editing technology.

  4. GMP-Compliant, Scalable Electroporation Platform For Non-Viral Cell Engineering 8/2/2024

    This presentation explores natural killer (NK) cells and how conditions for electroporating primary NK cells can be optimized to improve cell viability, transfection efficiency, and other factors.

  5. Gene Editing In Hematopoietic Stem Cells For Monogenic Blood Cell Diseases 8/2/2024

    Explore Cas9-mediated homology-directed repair and advancements in gene editing technologies that could significantly broaden the treatment possibilities for various blood disorders.

  6. CHOp Your Protein Production Timelines 7/30/2024

    How can you leverage flow electroporation technology to drive your biologics development forward and deliver gram-scale transient protein production within two weeks?